April 29, 2026
Kristy Ainslie, PhD, and colleagues were awarded a $12.8 million NIH Program Project grant to form a collaborative team researching biomaterials to boost the body’s own immune system to enhance cell-based immunotherapy to fight glioblastoma.
February 10, 2026
A dime-sized technology could transform CAR-T therapy by creating a simpler, more affordable procedure that targets many cancer types and can be done at almost any hospital.
December 15, 2025
Eleven UNC Lineberger Comprehensive Cancer Center members were named as 2025 Highly Cited Researchers by Clarivate for publishing some of the most influential scientific papers during the past decade.
November 25, 2025
November 1, 2025
Researchers found that inhibiting a problematic protein in the body helps immunotherapies and CAR-T therapy to better fight off melanoma.
January 14, 2025
Gianpietro Dotti, MD, and colleagues report in Nature Immunology they have identified a cocktail of three different drugs that can be used to generate more robust CAR-Ts to fight cancer.
November 26, 2024
Nine UNC Lineberger members wrote some of the most influential scientific papers in the past decade, according to an independent analysis of research publications.
October 7, 2024
Gianpietro Dotti, MD, and Xin Zhou, PhD, report in Nature Cancer that a novel immunotherapy approach utilizing natural killer T (NKT) cells produced significant antitumor activity in solid tumors.
March 1, 2024
UNC Lineberger researchers are using CAR-T to create better and personalized cancer treatments in one of the largest cell therapy facilities on the East Coast.
November 16, 2023
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2023 Highly Cited Researchers™ list, which recognized scientists who published papers that ranked in the top 1% of cited publications in their field between 2012-2022.